Literature DB >> 23323736

Recurrent ACTH-independent Cushing's syndrome in multiple pregnancies.

Jiao-jun Xu1, Yong-jian Wang, Li-zhen Shan, Wei Gu, Wen-heng Zeng.   

Abstract

A 27-year-old woman presented with Cushing's syndrome. Typical clinical symptoms and signs developed at the beginning of each pregnancy. The latest three pregnancies all ended with natural abortion at about three months. It was the fourth time that she was pregnant. By week 18 of gestation, plasma cortisol diurnal rhythm was absent, basal urinary free cortisol was 1650 μg/24 h and ACTH levels were suppressed. The diagnosis of ACTH-independent Cushing's syndrome was established. Cushing's syndrome in the patient resolved within four weeks of abortion. But signs and symptoms of hypercortisolism recurred in the fifth pregnancy and resolved soon after abortion during the follow-up. The mechanisms by which pregnancy-induced Cushing's syndrome occurred in this patient are unclear. Aberrant responsiveness or hyperresponsiveness of adrenocortical cells to a non-ACTH and non-CRH substance produced in excess in pregnancy should be considered.

Entities:  

Mesh:

Year:  2013        PMID: 23323736     DOI: 10.3109/09513590.2012.743014

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  3 in total

Review 1.  Cushing's syndrome during pregnancy caused by adrenal cortical adenoma: a case report and literature review.

Authors:  Wei Wang; Fengyi Yuan; Dan Xu
Journal:  Front Med       Date:  2015-08-13       Impact factor: 4.592

2.  Exacerbation of Cushing's syndrome during pregnancy: stimulation of a cortisol-secreting adrenocortical adenoma by ACTH originating from the foeto-placental unit.

Authors:  Matthieu St-Jean; Jessica MacKenzie-Feder; Isabelle Bourdeau; André Lacroix
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-02-07

Review 3.  The diagnosis and management of Cushing's syndrome in pregnancy.

Authors:  Ross Hamblin; Amy Coulden; Athanasios Fountas; Niki Karavitaki
Journal:  J Neuroendocrinol       Date:  2022-05-01       Impact factor: 3.870

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.